Cargando…

Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass

OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd editio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumoto, Muneto, Suzuki, Eiji, Nagata, Mayumi, Suzuki, Keisuke, Hirata, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076141/
https://www.ncbi.nlm.nih.gov/pubmed/35989269
http://dx.doi.org/10.2169/internalmedicine.0132-22
Descripción
Sumario:OBJECTIVES: Migraine is a disease that leads to social loss due to a decrease in productivity since it is a primary headache with a high prevalence and readily occurs in working-age persons. As described in the diagnostic criteria of the International Classification of Headache Disorders, 3rd edition (beta version), migraine causes hypersensitivity, especially photosensitivity, during attacks, suggesting that light is an inducer of headaches. We developed Blue Cut for Night (BCN) glass, which reduces light stimulation to intrinsically photosensitive continental ganglion cells (ipRGCs), photoreceptors that can lead to exacerbation of migraine attacks. METHODS: Ten patients with migraine participated in the study. Each participant was made to wear BCN glasses only at night for four weeks. The number of headache days and Headache Impact Test-6 values before and after using the BCN glasses were compared. RESULTS: When the 10 patients with migraine wore the BCN glass at night only for 4 weeks, the number of headache days within that time tended to decrease (7.0±4.37 days) compared to before wearing the glasses (8.7±5.03 days). No participants had any side effects. CONCLUSION: BCN glass, which reduces light stimulation to ipRGCs, was suggested to be a tool for reducing migraine attacks.